ClinicalTrials.Veeva

Menu

Renal Denervation in Patients After Acute Coronary Syndrome (ACSRD)

M

Meshalkin Research Institute of Pathology of Circulation

Status and phase

Unknown
Phase 2

Conditions

Acute Coronary Syndrome
Arterial Hypertension

Treatments

Drug: Lisinopril
Procedure: Renal denervation
Drug: Metoprolol

Study type

Interventional

Funder types

NETWORK

Identifiers

Details and patient eligibility

About

This study is aimed to evaluate the effect of renal denervation to decreasing blood pressure and left ventricle remodeling progression in patients after acute coronary syndrome.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • acute Q negative myocardium infarction (during first 14 days)
  • non stable angina
  • significant stenosis
  • BP > 140/90 torr. during more than 1 year

Exclusion criteria

  • absence of arterial hypertension
  • Thrombolysis during previous 24 hours
  • indications for CABG

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups

PCI+Renal denervation
Active Comparator group
Treatment:
Drug: Metoprolol
Procedure: Renal denervation
Drug: Lisinopril
PCI alone
Active Comparator group
Treatment:
Drug: Metoprolol
Drug: Lisinopril

Trial contacts and locations

1

Loading...

Central trial contact

Evgeny Pokushalov, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems